The former CEO of a biopharmaceutical company, who was held liable in 2021 for breaching his fiduciary duties but was ordered to pay a nominal sum of $1 after Delaware’s Court of Chancery found no substantial harm had occurred, is now pursuing a claim for his attorney’s fees and court costs. More details about this legal development can be found here.